Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death

Changfeng Li1, Ying Zhang1, Jiao Liu2

  • 1Department of Endoscopy Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.

Autophagy
|March 19, 2020
PubMed

Insights

Zalcitabine, an HIV drug, shows promise in treating pancreatic cancer by triggering ferroptosis, a cell death pathway. This occurs through mitochondrial DNA stress and autophagy, offering a new therapeutic strategy.

Area of Science:

  • Oncology
  • Cell Death Mechanisms
  • Drug Repurposing

Background:

  • Pancreatic cancer exhibits high therapeutic resistance and poor survival rates.
  • Current treatments for pancreatic cancer are limited.
  • Understanding novel cell death pathways is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the potential of zalcitabine, an antiviral medication, as a pancreatic cancer therapeutic.
  • To elucidate the mechanism by which zalcitabine affects pancreatic cancer cell growth.
  • To explore the role of ferroptosis and autophagy in zalcitabine's anticancer effects.

Main Methods:

  • Treatment of primary and immortalized human pancreatic cancer cells with zalcitabine.
  • Assessment of cell growth inhibition and induction of ferroptosis.
  • Analysis of mitochondrial DNA (mtDNA) stress and the STING1/TMEM173 pathway.
  • Investigation of macroautophagy/autophagy-dependent cell death and lipid peroxidation.
  • Genetic and pharmacological inactivation of the autophagy-dependent ferroptosis pathway in cell culture and animal models.

Main Results:

  • Zalcitabine suppressed the growth of human pancreatic cancer cells.
  • The drug induced ferroptosis, an iron-dependent form of regulated cell death.
  • This effect was mediated by zalcitabine-induced mitochondrial DNA stress activating the STING1/TMEM173 pathway.
  • Autophagy-dependent ferroptosis occurred via lipid peroxidation, independent of a type I interferon response.
  • Inactivation of the autophagy-dependent ferroptosis pathway abrogated zalcitabine's anticancer effects.

Conclusions:

  • Zalcitabine demonstrates potential as a novel therapeutic agent for pancreatic cancer.
  • The study highlights the critical role of autophagy-dependent ferroptosis in zalcitabine's mechanism of action.
  • Findings advance the understanding of the interplay between DNA damage response and autophagy in regulating cell death for cancer therapy.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.2K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.1K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.1K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
11.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K